ILoF

iLoF is a digital health company that pioneers an AI platform to accelerate personalized drug discovery and development. It uses AI and photonics to build a digital library of biomarkers and biological profiles.

Claim this tool

1View

At a glance

Pricing

Likely Not Free

Free tier

API

Skill level

Technical

About

What is iLoF?

iLoF is a digital health company at the forefront of personalized medicine, leveraging a breakthrough AI-platform to accelerate drug discovery and development. Their cloud-based library utilizes optical fingerprints, powered by photonics and AI, to provide non-invasive tracking, screening, and stratification for clinical trials. This innovative approach allows for efficient, flexible, and patient-centric drug development, requiring only microliters of blood and taking less than 10 seconds per sample. The platform aims to reduce costs by 40% and screening time by 70%, while improving the quality of candidate pools. iLoF is currently focusing on Alzheimer's, COVID-19, and Ovarian Cancer, building out its virtual fingerprint library to expand its applications to other diseases.

Best used for

Ideal for pharmaceutical companies and research institutions who need to accelerate drug discovery, improve patient stratification for clinical trials, and reduce the time and cost associated with screenings. Especially valuable for developing personalized medicine approaches for complex diseases like Alzheimer's and cancer.

Common actions

accelerate drug discovery

stratify patients

analyze biomarkers

reduce clinical trial costs

Capabilities

Key features

AI-powered optical fingerprinting
Non-invasive blood screening
Rapid sample analysis
Patient stratification
Digital biomarker library
Cost and time reduction

Target Audience

pharmaceutical researchersbiotech companiesclinical trial managersdrug developers

Integrations

Not yet documented

Pricing & Plans

Likely Not Free

Not publicly disclosed. Check ilof.tech for current pricing.

FAQs

What diseases does the iLoF platform currently focus on?

The iLoF platform is currently focused on Alzheimer's for early and differential screening, COVID-19 for forecasting clinical outcomes, and Ovarian Cancer for stratifying subtypes. They are actively expanding their virtual fingerprint library to address other diseases.

How does iLoF's technology reduce clinical trial costs and time?

iLoF's non-invasive blood-based screening test and AI-powered platform can lead to a 40% cost savings and a 70% reduction in time spent on screenings. This is achieved by providing a more qualified pool of candidates and streamlining the stratification process.

What is the core technology behind iLoF's platform?

The iLoF platform utilizes a cloud-based library of optical fingerprints, powered by photonics and artificial intelligence. This technology enables non-invasive tracking, screening, and stratification of patients for drug discovery, requiring only microliters of blood.

Trending

Subcategories trending in Wellness & Lifestyle

Clinical & Healthcare Pro Health & Fitness Gaming & Entertainment Mental Wellness Self-Improvement Medical & Symptom Checking

Trending

Also listed in

This tool also appears in

Research & Education › Academic Research

Explore

Browse AI tools by category

Content & Design Productivity & Business Coding & Development AI Agents & Automation Research & Education Wellness & Lifestyle Career Development Marketing & Growth Data & Analytics Customer Support & CX Finance E-commerce